Author

Annaliese Kramer

The University of Texas MD Anderson Cancer Center

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:genetic perturbation / CRISPR· 1 Organism:mouse· 1

Frequent Co-Authors

Amber Hoskins· 1 shared Andrew J. GundersoniD· 1 shared Anirban MaitraiD· 1 shared Ashton Pluchinsky· 1 shared Ashwath Seetharaman· 1 shared Elijah Kirschstein· 1 shared Elizabeth Adams· 1 shared Etsehiwot Girum Girma· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Amber Hoskins

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Targeting AXL Overcomes Adaptive Resistance to KRAS Inhibition in KRAS-Driven Cancer

Fredrik I. Thege, Annaliese Kramer, Norbert Kreisz, Intisar Salim, Etsehiwot Girum Girma, Linara Welte, Elizabeth Adams, Ashton Pluchinsky, Elijah Kirschstein, Olivia E. Harder, Amber Hoskins, Ashwath Seetharaman, Kimal Rajapakshe, Yuki Makino, Andrew J. Gunderson, , Anirban Maitra

This study identifies AXL as a driver of adaptive resistance to KRAS inhibition and shows that combining AXL and KRAS inhibition improves tumor control and immune response in lung and pancreatic cancer models.

bioRxiv · Aug 4, 2026 · PreprintCancer Biology